Ishita Drugs & Industries Balance Sheet Annual

BSE: 524400 | NSE: - | ISIN: INE806D01016 | Sector: Biotechnology & Drugs

89.02 +2.96 (3.44%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	2.98	2.82	2.70	0.79
Cash Equivalents	1.83	0.61	1.99	1.75
Short Term Investments	3.07	3.12	3.79	2.88
Cashand Short Term Investments	7.87	6.55	8.48	5.42
Accounts Receivable- Trade Net	0.70	1.80	0.54	1.52
Total Receivables Net	0.70	2.00	0.57	1.89
Total Inventory	1.06	1.60	0.97	0.65
Other Current Assets Total	0.02	0.03	0.02	0.03
Total Current Assets	9.66	10.18	10.05	7.99
Property/ Plant/ Equipment Total- Net	0.80	0.89	0.88	1.00
Long Term Investments	0.27	0.27	0.27	0.23
Note Receivable- Long Term	0.08	0.07	0.05	0.05
Total Assets	10.81	11.41	11.25	9.26
Accounts Payable	0.46	0.86	2.04	0.98
Current Portof LT Debt/ Capital Leases	0.00	0.96	0.00	0.00
Other Currentliabilities Total	0.41	0.40	0.59	0.45
Total Current Liabilities	0.87	2.21	2.63	1.43
Long Term Debt	0.00	-	-	0.00
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.00	0.96	0.00	0.00
Deferred Income Tax	0.02	0.02	0.03	0.04
Other Liabilities Total	0.00	0.00	0.00	-
Total Liabilities	0.89	2.23	2.66	1.47
Common Stock Total	2.99	2.99	2.99	2.99
Other Equity Total	6.93	6.18	5.61	4.80
Total Equity	9.92	9.17	8.60	7.79
Total Liabilities Shareholders' Equity	10.81	11.41	11.25	9.26
Total Common Shares Outstanding	0.30	0.30	0.30	0.30
Tangible Book Valueper Share Common Eq	33.18	30.68	28.75	26.05
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00